D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

NRX Pharmaceuticals, Inc. +11.83% Pre

NRX Pharmaceuticals, Inc.

NRXP

2.08

2.07

+11.83%

-0.48% Pre
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ: NRXP) with a Buy and maintains $34 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via